financetom
Business
financetom
/
Business
/
Automotive supplier Martinrea's Q2 sales beat estimates
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Automotive supplier Martinrea's Q2 sales beat estimates
Aug 12, 2025 2:24 PM

Overview

* Martinrea ( MRETF ) Q2 sales C$1.28 bln, beating analyst expectations

* Adjusted EPS for Q2 rises 13.8% yr/yr to C$0.66

* Co announces C$40 mln in new business awards

Outlook

* Martinrea ( MRETF ) maintains 2025 sales outlook of C$4.8 to C$5.1 bln

* Company expects 2025 adjusted operating income margin of 5.3% to 5.8%

* Martinrea ( MRETF ) projects 2025 free cash flow of C$125 to C$175 mln

Result Drivers

* INCREASED PRODUCTION - Vehicle production volumes rose as inventories returned to normal levels, boosting margins

* OPERATIONAL IMPROVEMENTS - Cost reductions and investments in machine learning enhanced productivity

* TARIFF MANAGEMENT - USMCA-compliant parts exempt from tariffs, while exposure to other tariffs remains manageable

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q2 Sales Beat C$1.28 C$1.24

bln bln (5

Analysts

)

Q2 EPS C$0.52

Q2 C$165.40

Adjusted mln

EBITDA

Q2 C$0.05

Dividend

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the auto, truck & motorcycle parts peer group is "buy"

* Wall Street's median 12-month price target for Martinrea International Inc ( MRETF ) is C$11.63, about 28.5% above its August 11 closing price of C$8.31

* The stock recently traded at 4 times the next 12-month earnings vs. a P/E of 4 three months ago

Press Release:

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Medical device maker Stryker announces $4.9 bln deal for Inari Medical
Medical device maker Stryker announces $4.9 bln deal for Inari Medical
Jan 6, 2025
* Inari shares rise nearly 20% on acquisition news * Deal could enhance Stryker's venous disease treatment offerings (Recasts first paragraph to change sourcing and updates shares in paragraph 5) By Anirban Sen NEW YORK, Jan 6 (Reuters) - Stryker said on Monday that the medical-device maker will buy Inari Medical ( NARI ), which makes devices that treat patients...
Denali Therapeutics ALS drug fails in mid-stage trial
Denali Therapeutics ALS drug fails in mid-stage trial
Jan 6, 2025
Jan 6 (Reuters) - Denali Therapeutics ( DNLI ) said on Monday its experimental drug failed to meet the main goal of a mid-to-late stage trial in patients with amyotrophic lateral sclerosis (ALS), a fatal neurodegenerative disease. ...
Butler National Insider Bought Shares Worth $268,607, According to a Recent SEC Filing
Butler National Insider Bought Shares Worth $268,607, According to a Recent SEC Filing
Jan 6, 2025
04:39 PM EST, 01/06/2025 (MT Newswires) -- Joseph Patrick Daly, 10% Owner, Director, on January 03, 2025, executed a purchase for 157,800 shares in Butler National ( BUKS ) for $268,607. Following the Form 4 filing with the SEC, Daly has control over a total of 8,358,000 shares of the company, with 4,110,000 shares held directly and 4,248,000 controlled indirectly....
Roadzen Closes $5 Million Public Offering
Roadzen Closes $5 Million Public Offering
Jan 6, 2025
04:40 PM EST, 01/06/2025 (MT Newswires) -- Roadzen ( RDZN ) closed its public offering of 2.22 million ordinary shares at $2.25 apiece for gross proceeds of $5 million. Net proceeds will be mainly for costs related to sales and marketing, for research and development, working capital and general corporate purposes, the company said Monday in a statement. Roadzen (...
Copyright 2023-2026 - www.financetom.com All Rights Reserved